AMN Healthcare (AMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AMN Healthcare is rated a buy due to its historically low valuation and strong long-term prospects in the healthcare staffing industry. Despite recent revenue declines post-pandemic, the long-term demand for healthcare services and staffing is expected to grow significantly, benefiting AMN Healthcare. The company leverages advanced technology to streamline recruitment processes, enhancing its competitive edge and making it a valuable partner for healthcare providers.
AMN Healthcare aims to enhance staffing efficiency and improve operational efficiency in healthcare systems via the latest launch.
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
AMN shows growth potential with its broad services and high demand but faces challenges from industry regulations and strong competition in the staffing space.
Investors need to pay close attention to AMN Healthcare (AMN) stock based on the movements in the options market lately.
The healthcare industry has been a critical part of the economy for a long time. According to a McKinsey & Company report, the healthcare industry is expected to grow at 7% from 2022 to 2027.
AMN Healthcare's (AMN) dismal results in the majority of its segments led to a soft overall second-quarter performance.
AMN Healthcare Services, Inc. (NYSE:AMN ) Q2 2024 Earnings Conference Call August 8, 2024 5:00 PM ET Company Participants Randle Reece - Senior Director-IR Cary Grace - President and CEO Jeff Knudson - CFO Conference Call Participants Trevor Romeo - William Blair Brian Tanquilut - Jefferies Jeff Silber - BMO Capital Markets A.J. Rice - UBS Mark Marcon - Baird Kevin Fischbeck - Bank of America Tobey Sommer - Truist Securities Bill Sutherland - Benchmark Company Operator Good day, and thank you for standing by.
Although the revenue and EPS for AMN Healthcare (AMN) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
AMN Healthcare Services (AMN) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $2.38 per share a year ago.
Besides Wall Street's top -and-bottom-line estimates for AMN Healthcare (AMN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2024.